Cardiovascular Systems (FRA:R7Y1) Debt-to-Revenue : 0.09 (As of Dec. 2022)

Cardiovascular Systems Debt-to-Revenue Chart

Cardiovascular Systems Annual Data
	Trend	Jun13	Jun14	Jun15	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22
Debt-to-Revenue		Get a 7-Day Free Trial					0.10	0.09	0.09	0.09	0.09

Cardiovascular Systems Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Debt-to-Revenue	Get a 7-Day Free Trial															0.09	0.10	0.09	0.09	0.09

Competitive Comparison of Cardiovascular Systems's Debt-to-Revenue

For the Medical Devices subindustry, Cardiovascular Systems's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cardiovascular Systems's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cardiovascular Systems's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cardiovascular Systems's Debt-to-Revenue falls into.

Cardiovascular Systems Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Cardiovascular Systems's Debt-to-Revenue for the fiscal year that ended in Jun. 2022 is calculated as

Cardiovascular Systems's annualized Debt-to-Revenue for the quarter that ended in Dec. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2022) Revenue data.

Cardiovascular Systems Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cardiovascular Systems's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardiovascular Systems (FRA:R7Y1) Business Description